These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2960959)

  • 21. Testosterone-induced DNA synthesis in cultured rat ventral prostate. I. Effects of cyproterone acetate.
    Buchanan LJ; Riches AC
    J Anat; 1986 Oct; 148():159-67. PubMed ID: 2961721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
    de Voogt HJ
    Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of low-dosage oral cyproterone acetate as a male contraceptive.
    Wang C; Yeung KK
    Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of artificial photoperiodicity and antiandrogen treatment on the antler growth and plasma levels of LH, FSH, testosterone, prolactin and alkaline phosphatase in the male white-tailed deer.
    Bubenik GA; Schams D; Coenen G
    Comp Biochem Physiol A Comp Physiol; 1987; 87(3):551-9. PubMed ID: 2887340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estrogens on luteinizing hormone release in testicular feminization syndrome before and after gonadectomy.
    Corsello SM; De Rosa G; Liberale I; Menini E; Moneta E; Pasargiklian E
    Obstet Gynecol; 1984 Mar; 63(3):312-7. PubMed ID: 6230548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
    Frey H; Aakvaag A
    Acta Obstet Gynecol Scand; 1981; 60(3):295-300. PubMed ID: 6455899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial patterns during danazol and cyproterone acetate treatment for endometriosis: structural and ultrastructural study.
    Marchini M; Fedele L; Bianchi S; Arcaini L; Brioschi D; Di Nola G
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(2):137-43. PubMed ID: 1830018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen dependence of glutathione metabolism in ventral prostate.
    Vijayvargiya R; Singhal RL
    Biochem Pharmacol; 1983 Sep; 32(17):2607-10. PubMed ID: 6225436
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
    Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
    J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB; Ibraham I; Edwards CR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 32. Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen.
    Gooren L; Spinder T; Spijkstra JJ; van Kessel H; Smals A; Rao BR; Hoogslag M
    J Clin Endocrinol Metab; 1987 Apr; 64(4):763-70. PubMed ID: 3102546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of tamoxifen on the feminization of chick embryo testis].
    Weniger JP; Samsel J; Chouraqui J; Zeis A
    Ann Endocrinol (Paris); 1983; 44(2):139-42. PubMed ID: 6225370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
    Parr JH; Seed M; Godsland I; Wynn V
    J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
    Armstrong VL; Wiggam MI; Ennis CN; Sheridan B; Traub AI; Atkinson AB; Bell PM
    QJM; 2001 Jan; 94(1):31-7. PubMed ID: 11161134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine effects of cyproterone acetate in patients with prostatic cancer.
    Isurugi K; Fukutani K; Ishida H; Hosoi Y
    J Urol; 1980 Feb; 123(2):180-3. PubMed ID: 7354512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
    Obiezu CV; Giltay EJ; Magklara A; Scorilas A; Gooren L; Yu H; Diamandis EP
    J Urol; 2000 Mar; 163(3):802-5. PubMed ID: 10687981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
    Steinsapir J; Mora G; Muldoon TG
    Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of castration and antiandrogens (RU 23908 and cyproterone acetate) on glandulain activity and on the secretory epithelium of the rat submandibular gland.
    Porto CS; Picarelli ZP; Hayashi H; Abreu LC
    Braz J Med Biol Res; 1988; 21(3):591-8. PubMed ID: 2976284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The mechanism of action of cyproterone acetate in the treatment of hirsutism].
    Rigaud C; Vincens M; Mowszowicz I; Wright F; Mavier P; Nahoul K; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    Ann Endocrinol (Paris); 1983; 44(6):387-92. PubMed ID: 6234849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.